FILAMENT HEALTH CORP.

Insiders Filament Health Corp.

Equities

FLHL.F

CA31685W1068

Market Closed - OTC Markets Other stock markets 01:20:34 2024-06-07 pm EDT			5-day change	1st Jan Change
0.0346 ^USD	-13.62%		-12.63%	-36.04%

Jun. 03	Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder	CI
Jun. 03	Filament Health Corp. announced that it expects to receive CAD 1 million in funding from Negev Capital and another investor	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Filament Health Corp. Announces Change to Board of Directors	May. 03	CI
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee	Mar. 28	CI
Filament Health Announces Change to Board of Directors	Jan. 02	CI
Jaguar Health, Inc., Filament Health Corp. and One Small Planet, LLC Announces Formation of a U.S.-Based Joint Venture Named Magdalena Biosciences, Inc	23-01-10	CI
Filament Health Corp. Announces Change to Board of Directors	22-12-30	CI
Filament Health Corp. Announces the Appointment of Dr. Konstantin Adamsky to Board of Directors, and Jeff Chilton of Nammex to the Advisory Council	22-08-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer